Lung Cancer in Women: Role of Estrogens

Overview

Journal Expert Rev Respir Med

Specialty Pulmonary Medicine

Date 2010 Jul 28

PMID 20658912

Citations 34

Authors

Subhankar Chakraborty

Apar Kishor Ganti

Alissa Marr

Surinder K Batra

Affiliations

Soon will be listed here.

Abstract

The incidence of lung cancer in females is increasing, in contrast to that seen in males. In addition, the proportion of lung cancer cases in women attributable to smoking is approximately half of that seen in males. Female sex hormones, especially estrogen, may play a key role in this. Estrogen receptors ERalpha and ERbeta have been detected on lung cancer cells and there is new evidence suggesting that hormone-replacement therapy may increase both the incidence of, and mortality from, lung cancer in women. Laboratory evidence lends credence to the carcinogenic effects of estrogens in lung cancer. This article summarizes the current evidence on their role in lung cancer.

Citing Articles

Chromatin accessibility reveals potential prognostic value of the peak set associated with smoking history in patients with lung adenocarcinoma.

Liang H, Deng J, Luo T, Luo H, Li F, Wu K Heliyon. 2024; 10(24):e41006.

PMID: 39720074 PMC: 11665461. DOI: 10.1016/j.heliyon.2024.e41006.

Analysis of Modular Hub Genes and Therapeutic Targets across Stages of Non-Small Cell Lung Cancer Transcriptome.

Barretto A, Orda M, Tsai P, Tayo L Genes (Basel). 2024; 15(10).

PMID: 39457373 PMC: 11507033. DOI: 10.3390/genes15101248.

The Formation of Stable Lung Tumor Spheroids during Random Positioning Involves Increased Estrogen Sensitivity.

Barkia B, Sandt V, Melnik D, Cortes-Sanchez J, Marchal S, Baselet B Biomolecules. 2024; 14(10).

PMID: 39456226 PMC: 11506229. DOI: 10.3390/biom14101292.

Development of a genome atlas for discriminating benign, preinvasive, and invasive lung nodules.

Liang P, Peng M, Tao J, Wang B, Wei J, Lin L MedComm (2020). 2024; 5(8):e644.

PMID: 39036344 PMC: 11258453. DOI: 10.1002/mco2.644.

A three-year review of lung cancer patient characteristics in a tertiary hospital.

Afriyie-Mensah J, Kwarteng E, Tetteh J, Gbadamosi H, Dadzie M, Mensah Y Ghana Med J. 2024; 57(3):167-174.

PMID: 38957673 PMC: 11216727. DOI: 10.4314/gmj.v57i3.2.

References

Hershberger P, Vasquez A, Kanterewicz B, Land S, Siegfried J, Nichols M . Regulation of endogenous gene expression in human non-small cell lung cancer cells by estrogen receptor ligands. Cancer Res. 2005; 65(4):1598-605. DOI: 10.1158/0008-5472.CAN-04-2694. View

McClay E, Bogart J, Herndon 2nd J, Watson D, Evans L, Seagren S . A phase III trial evaluating the combination of cisplatin, etoposide, and radiation therapy with or without tamoxifen in patients with limited-stage small cell lung cancer: Cancer and Leukemia Group B Study (9235). Am J Clin Oncol. 2005; 28(1):81-90. DOI: 10.1097/01.coc.0000139940.52625.d0. View

Smith J, Barrett-Connor E, Kritz-Silverstein D, Wingard D, Al-Delaimy W . Hormone use and lung cancer incidence: the Rancho Bernardo cohort study. Menopause. 2009; 16(5):1044-8. PMC: 2743860. DOI: 10.1097/gme.0b013e3181a1ba04. View

Gruber C, Tschugguel W, Schneeberger C, Huber J . Production and actions of estrogens. N Engl J Med. 2002; 346(5):340-52. DOI: 10.1056/NEJMra000471. View

Ayeni O, Robinson A . Hormone replacement therapy and outcomes for women with non-small-cell lung cancer: can an association be confirmed?. Curr Oncol. 2009; 16(3):21-5. PMC: 2695714. DOI: 10.3747/co.v16i3.302. View

Fasco M, Hurteau G, Spivack S . Gender-dependent expression of alpha and beta estrogen receptors in human nontumor and tumor lung tissue. Mol Cell Endocrinol. 2002; 188(1-2):125-40. DOI: 10.1016/s0303-7207(01)00750-x. View

Schabath M, Wu X, Vassilopoulou-Sellin R, Vaporciyan A, Spitz M . Hormone replacement therapy and lung cancer risk: a case-control analysis. Clin Cancer Res. 2004; 10(1 Pt 1):113-23. DOI: 10.1158/1078-0432.ccr-0911-3. View

Stabile L, Gaither Davis A, Gubish C, Hopkins T, Luketich J, Christie N . Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen. Cancer Res. 2002; 62(7):2141-50. View

Kaiser U, Hofmann J, Schilli M, Wegmann B, Klotz U, Wedel S . Steroid-hormone receptors in cell lines and tumor biopsies of human lung cancer. Int J Cancer. 1996; 67(3):357-64. DOI: 10.1002/(SICI)1097-0215(19960729)67:3<357::AID-IJC9>3.0.CO;2-Q. View

10.

Campbell R, Bhat-Nakshatri P, Patel N, Constantinidou D, Ali S, Nakshatri H . Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance. J Biol Chem. 2001; 276(13):9817-24. DOI: 10.1074/jbc.M010840200. View

11.

Blackman J, Coogan P, Rosenberg L, Strom B, Zauber A, Palmer J . Estrogen replacement therapy and risk of lung cancer. Pharmacoepidemiol Drug Saf. 2002; 11(7):561-7. DOI: 10.1002/pds.733. View

12.

Weinberg O, Marquez-Garban D, Fishbein M, Goodglick L, Garban H, Dubinett S . Aromatase inhibitors in human lung cancer therapy. Cancer Res. 2005; 65(24):11287-91. DOI: 10.1158/0008-5472.CAN-05-2737. View

13.

Moore K, Mery C, Jaklitsch M, Estocin A, Bueno R, Swanson S . Menopausal effects on presentation, treatment, and survival of women with non-small cell lung cancer. Ann Thorac Surg. 2003; 76(6):1789-95. DOI: 10.1016/s0003-4975(03)01024-5. View

14.

Schwartz A, Wenzlaff A, Prysak G, Murphy V, Cote M, Brooks S . Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women. J Clin Oncol. 2007; 25(36):5785-92. DOI: 10.1200/JCO.2007.13.3975. View

15.

Su J, Hsu H, Chang H, Lin S, Chang H, Huang M . Expression of estrogen and progesterone receptors in non-small-cell lung cancer: immunohistochemical study. Anticancer Res. 1996; 16(6B):3803-6. View

16.

Burger H . Androgen production in women. Fertil Steril. 2002; 77 Suppl 4:S3-5. DOI: 10.1016/s0015-0282(02)02985-0. View

17.

Ganti A, Sahmoun A, Panwalkar A, Tendulkar K, Potti A . Hormone replacement therapy is associated with decreased survival in women with lung cancer. J Clin Oncol. 2005; 24(1):59-63. DOI: 10.1200/JCO.2005.02.9827. View

18.

Bray F, Tyczynski J, Parkin D . Going up or coming down? The changing phases of the lung cancer epidemic from 1967 to 1999 in the 15 European Union countries. Eur J Cancer. 2003; 40(1):96-125. DOI: 10.1016/j.ejca.2003.08.005. View

19.

Hammoud Z, Tan B, Badve S, Bigsby R . Estrogen promotes tumor progression in a genetically defined mouse model of lung adenocarcinoma. Endocr Relat Cancer. 2008; 15(2):475-83. DOI: 10.1677/ERC-08-0002. View

20.

Taioli E, Wynder E . Re: Endocrine factors and adenocarcinoma of the lung in women. J Natl Cancer Inst. 1994; 86(11):869-70. DOI: 10.1093/jnci/86.11.869. View